Glaukos Corporation (GKOS) Income Statement

NYSE: GKOSRevenue, profits, margins and EPS over 10 years.

GKOS 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+32.3%
$507.4M
2025 · hover or tap a bar for each year
2016: $114.4M (+59.5%)2017: $159.3M (+39.2%)2018: $181.3M (+13.8%)2019: $237.0M (+30.7%)2020: $225.0M (−5.1%)2021: $294.0M (+30.7%)2022: $282.9M (−3.8%)2023: $314.7M (+11.3%)2024: $383.5M (+21.9%)2025: $507.4M (+32.3%)
20162025
Gross profit+35.8%
$393.2M
2025 · hover or tap a bar for each year
2016: $98.2M (+67.3%)2017: $138.2M (+40.7%)2018: $156.2M (+13.0%)2019: $198.4M (+27.0%)2020: $133.2M (−32.8%)2021: $227.4M (+70.7%)2022: $213.9M (−5.9%)2023: $239.1M (+11.8%)2024: $289.5M (+21.0%)2025: $393.2M (+35.8%)
20162025
Operating income
−$86.7M
2025 · hover or tap a bar for each year
2016: $4.2M2017: −$2.3M (−153.8%)2018: −$13.0M2019: −$50.3M2020: −$123.6M2021: −$32.9M2022: −$82.3M2023: −$128.7M2024: −$122.4M2025: −$86.7M
20162025
Net income
−$187.7M
2025 · hover or tap a bar for each year
2016: $4.5M2017: −$92,000 (−102.0%)2018: −$13.0M2019: $15.4M2020: −$120.3M (−880.3%)2021: −$49.6M2022: −$99.2M2023: −$134.7M2024: −$146.4M2025: −$187.7M
20162025
EPS (diluted)
−$1.52
2025 · hover or tap a bar for each year
2016: $0.122017: $0.15 (+25.0%)2018: −$0.38 (−353.3%)2019: −$0.312020: −$1.962021: −$0.842022: −$2.192023: −$2.272024: −$1.902025: −$1.52
20162025
Net profit margin+1.2 pts
−37.0%
2025 · hover or tap a point for each year
2016: 4.0% (+55.9 pts)2017: −0.1% (−4.0 pts)2018: −7.1% (−7.1 pts)2019: 6.5% (+13.7 pts)2020: −53.5% (−60.0 pts)2021: −16.9% (+36.6 pts)2022: −35.1% (−18.2 pts)2023: −42.8% (−7.7 pts)2024: −38.2% (+4.6 pts)2025: −37.0% (+1.2 pts)
20162025

GKOS revenue and net income

RevenueNet incomeNet margin (right axis)

Where GKOS's revenue goes

2025
Revenue
$507.4M100.0%
Cost of revenue
−$114.2M−22.5%
Gross profit
$393.2M77.5%
Research & development
−$150.6M−29.7%
Sales, general & admin
−$331.7M−65.4%
Operating income
−$86.7M−17.1%
Interest & other expense
−$106.3M−20.9%
Income taxes
$5.4M1.1%
Net income
−$187.7M−37.0%

Each bar shows an amount and its share of revenue. GKOS kept −37.0% of revenue as net income.

GKOS profit margins

GrossOperatingNet

GKOS growth rates

to 2025
1 year3 years5 years10 years
Revenue+32.3%+21.5%+17.7%+21.6%
Gross profit+35.8%+22.5%+24.2%+20.9%
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

GKOS quarterly EPS vs estimates

Reported EPSAnalyst estimate

Glaukos beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: October 28, 2026 (estimate $-0.12).

GKOS income statement

Glaukos Corporation annual income statement
2025202420232022202120202019201820172016
Revenue$507.4M$383.5M$314.7M$282.9M$294.0M$225.0M$237.0M$181.3M$159.3M$114.4M
Cost of revenue$114.2M$94.0M$75.6M$69.0M$66.6M$91.7M$38.6M$25.1M$21.1M$16.2M
Gross profit$393.2M$289.5M$239.1M$213.9M$227.4M$133.2M$198.4M$156.2M$138.2M$98.2M
Research & development$150.6M$136.4M$138.8M$123.3M$101.0M$85.4M$68.3M$49.7M$38.9M$29.2M
Sales, general & admin$331.7M$262.8M$224.1M$190.4M$178.1M$171.4M$176.6M$121.3M$96.3M$64.8M
Total operating expenses$479.9M$411.8M$367.8M$296.2M$260.3M$256.8M$248.7M$169.2M$140.5M$94.0M
Operating income−$86.7M−$122.4M−$128.7M−$82.3M−$32.9M−$123.6M−$50.3M−$13.0M−$2.3M$4.2M
Interest income$10.7M$11.1M$9.2M$2.4M$1.3M$2.4M$3.2M$2.3M$2.3M$889,000
Interest expense$4.6M$10.0M$13.6M$13.7M$13.4M$14.1M$2.6M$0$44,000$608,000
Income before taxes−$193.0M−$145.6M−$133.7M−$98.4M−$49.3M−$132.3M−$50.0M−$12.4M$1,000$4.6M
Income taxes−$5.4M$771,000$934,000$766,000$326,000−$12.0M−$65.5M$583,000$93,000$43,000
Net income−$187.7M−$146.4M−$134.7M−$99.2M−$49.6M−$120.3M$15.4M−$13.0M−$92,000$4.5M
EBITDA−$146.1M−$95.6M−$82.1M−$48.8M−$1.5M−$83.6M−$37.6M−$6.7M$5.5M$9.0M
EPS (diluted)−$1.52−$1.90−$2.27−$2.19−$0.84−$1.96−$0.31−$0.38$0.15$0.12
Gross margin77.5%75.5%76.0%75.6%77.3%59.2%83.7%86.2%86.8%85.9%
Operating margin−17.1%−31.9%−40.9%−29.1%−11.2%−54.9%−21.2%−7.2%−1.4%3.7%
Net margin−37.0%−38.2%−42.8%−35.1%−16.9%−53.5%6.5%−7.1%−0.1%4.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in GKOS's financial statements (latest annual report filed February 23, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

GKOS financial results

In fiscal year 2025 (ended December 31, 2025), Glaukos reported revenue of $507.4 million, up 32.3% from the year before. It had a net loss of $187.7 million, a net profit margin of −37.0%. Diluted earnings per share came to −$1.52. Over five years revenue grew at an average rate of 17.7% a year.

See the GKOS stock overview for the latest quote and news, or the GKOS chart for price history and technical indicators.

GKOS income statement FAQ

What is Glaukos's annual revenue?

Glaukos reported total revenue of $507.4 million for fiscal year 2025, which ended on December 31, 2025. That was up 32.3% from $383.5 million the previous year.

Is Glaukos profitable?

No. Glaukos reported a net loss of $187.7 million in fiscal 2025, a net profit margin of −37.0%; its operating margin was −17.1%.

What is Glaukos's gross margin?

Glaukos's gross margin was 77.5% in fiscal 2025: for every $100 of revenue, Glaukos kept $77 after the direct cost of its products and services.

How much does Glaukos spend on research and development?

Glaukos spent $150.6 million on research and development in fiscal 2025, 29.7% of revenue.

How fast is Glaukos growing?

Revenue grew 17.7% a year on average over the last five fiscal years, from $225.0 million to $507.4 million.

What are Glaukos's earnings per share?

Glaukos earned $-1.52 per diluted share in fiscal 2025, compared with $-1.90 a year earlier.

When will Glaukos report its next earnings?

Glaukos is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes.

When does Glaukos's fiscal year end?

Glaukos's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 23, 2026.

Medical Devices income statements